The firm currently offers a multi-cancer detection test as an opt-in for patients receiving its Shield colorectal cancer screening assay.
The firms will integrate their technologies into a single workflow and jointly engage in initiatives to raise awareness of AI-based precision oncology testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results